Generation of spinocerebellar ataxia type 2 patient-derived iPSC line H196

Stem Cell Res. 2016 Jan;16(1):199-201. doi: 10.1016/j.scr.2015.12.049. Epub 2016 Jan 15.

Abstract

Spinocerebellar ataxia type 2 (SCA2) is a neurodegenerative disease primarily affecting the cerebellum. Very little is known about the molecular mechanisms underlying the disease and, to date, no cure or treatment is available. Here, we demonstrate the generation of an induced pluripotent stem cell (iPSC) line of a SCA2 patient. The selected clone has been proven to be a bona fide iPSC line, which retains a normal karyotype. Due to its differentiation potential into neurons, this iPSC line will be a valuable tool in studying a disease-specific phenotype of SCA2.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alleles
  • Ataxin-2 / genetics
  • Base Sequence
  • Cell Differentiation
  • Cell Line
  • Cellular Reprogramming
  • Humans
  • Induced Pluripotent Stem Cells / cytology*
  • Induced Pluripotent Stem Cells / metabolism
  • Karyotype
  • Male
  • Molecular Sequence Data
  • Plasmids / metabolism
  • Sequence Analysis, DNA
  • Spinocerebellar Ataxias / metabolism
  • Spinocerebellar Ataxias / pathology*
  • Transcription Factors / genetics
  • Transcription Factors / metabolism
  • Transfection

Substances

  • ATXN2 protein, human
  • Ataxin-2
  • Transcription Factors